Molinaro A, Braadland PR, Carpino G, Carreras A, Nikolaidis M, Hanzely P, Beck KR, Ali AH, Bossen L, Frank A, Lundqvist A, Juran BD, Overi D, Geng L, Amundsen-Isaksen E, Reims HM, Björk I, Grzyb K, Abildgaard A, Folseraas T, Cornillet M, Helgadóttir H, McCauley BM, Cristoferi L, Carbone M, Cardinale V, Høivik ML, Engesæter LK, Tjønnfjord SKV, McCann A et al. (2026)
Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling
Nat Metab (in press)
DOI 10.1038/s42255-026-01600-1, PubMed 42698000

Iversen PO, Holm K, Bang C, Tjønnfjord GE, Gedde-Dahl T, Ali MM, Hov JR (2026)
Extracorporeal photopheresis as GVHD prophylaxis: No impact on gut microbiota-a randomized controlled trial
Br J Haematol (in press)
DOI 10.1111/bjh.70831, PubMed 42687407

Juran BD, McCauley BM, Hu C, Ali AH, Schlicht EM, Bianchi JK, Schell MJ, Atkinson EJ, Hov JR, Vesterhus M, Rosenberg W, LaRusso NF, Gores GJ, Karlsen TH, Lazaridis KN (2026)
Bile Acid Profiles Define Disease-Specific Cholestatic States in Primary Sclerosing and Primary Biliary Cholangitis
Gastro Hep Adv, 5 (10), 101073
DOI 10.1016/j.gastha.2026.101073, PubMed 42668455